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ment of valid and reliable measures for compliance
behavior is still needed.
PHP6
THE INFLUENCE OF SELF-EFFICACY AND
COMPLIANCE IN HYPERTENSION PATIENTS,
DIABETES PATIENTS,AND UPPER RESPIRATORY
TRACT INFECTIOUS PATIENTS WHO NEED
SHORT COURSE ANTIBIOTICS AT FORT
ADISORN HOSPITAL,THAIALND 2000
Auamnoy Ti,Auamnoy Th
Chulalongkorn University, Bangkok,Thailand
OBJECTIVE: This study: 1) investigates the relationship
between Self-efﬁcacy (SE) (conﬁdence in competent in a
speciﬁc situation) and compliance with medical regimens
in three groups of patients namely: Chronic maintenance
care for diabetes—a life-threatening illness; Similar 
care for hypertension—a non-life threatening disease, and
Acute care with antibiotics for infection—an episodic 
disorder with or without life-threatening potential; 2)
explores SE for different levels of compliance (with 3 
diseases) in self-administration of prescribed drugs; 3)
identiﬁes other variables relating to compliance in the
respondents at Adisorn Fort, Saraburi Province, Thailand
2001. METHOD: A descriptive cross-sectional survey
was employed to study relationships between SE and
compliance. The response rate was 100% (n = 180). De
Geese’s SE Scale had alpha .8680 and Sorofman’s 
Compliance scale with 2 constructs (correct amount and
correct time) had alpha .8280 and .9459. RESULTS:
Research conﬁrmed that the stronger a patient’s Self-
efﬁcacy, the more reliably he/she complied to regimens 
for self-administration of maintenance and acute-care
medication. SE selectively predicted adherence in 3 dis-
tinct categories of drug therapy: Diabetes > Hypertension
> Antibiotics and compliance in Diabetes > Hypertension
> Antibiotics as well (p < .05). Statistical signiﬁcance for
predicting compliance was found in SE model (R2.695).
Male had more SE and comply than female (p < .05).
There were inverse correlation between education and SE
and negatively correlation between SE and compliance as
well (R-.199,-.189). The length of time for patients got
disease correlated to SE and compliance (R.475, .508) (p
< .05). The elderly had the more SE and more compliance
to medical regimens than the younger (R .415, .404).
Social support inﬂuenced SE and compliance. Patients
with spouses had more SE and more comply with medical
regimens than patients who lived alone (p < .05). CON-
CLUSION: SE played an important role in predicting
compliance. SE was selective among diseases.
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CRITICAL EVALUATION OF INTERVENTIONS
TO ENHANCE PATIENT COMPLIANCE WITH
CHRONIC MEDICATIONS
Petrilla AA, Benner JS
ValueMedics Research, LLC, Alexandria,VA, USA
OBJECTIVE: Compliance with chronic medications 
is poor, resulting in lost clinical beneﬁts and wasted
resources. Developing evidence-based compliance pro-
grams is difﬁcult because the literature is often equivocal,
contradictory, or of poor methodological quality. The
objectives of this study were: 1) to assess the relationship
between methodological rigor in program evaluation and
probability of intervention success; and 2) to identify 
the characteristics of compliance interventions that most
strongly predict positive outcomes. METHODS: We
searched the MEDLINE database for controlled studies
of interventions designed to improve patient compliance
with prescription medications for asthma, dyslipidemia,
hypertension, depression, and diabetes (English-only,
published between 1982 and 2002). Each study was
abstracted for methodological rigor and intervention
design. Compliance programs were considered “success-
ful” if the authors demonstrated a statistically signiﬁcant
improvement in compliance compared to a control group.
RESULTS: Sixty-four controlled studies were identiﬁed,
in which 76 compliance interventions were evaluated.
Overall, 68% of the interventions improved compliance.
Of 20 interventions evaluated based on self-reported
compliance, 9 (45%) were successful; 41 of 54 interven-
tions (76%) that measured compliance via pill count,
electronic monitoring, or pharmacy records were suc-
cessful (p = 0.02). There were nine broad categories 
of intervention types, the most frequent of which were
improved dosing convenience (n = 20 interventions, 
70% successful), intensive clinician management (n = 7,
57% successful), counseling (n = 7, 57% successful), and
reminders (n = 6, 66% successful). In addition, 20 of 
25 programs (80%) consisting of multiple interventions
were successful. CONCLUSION: Reliance on self-
reported medication use appears to bias results against
the intervention. This may be because patients report
exaggerated levels of compliance in both intervention 
and control groups, creating a “ceiling effect” that
reduces the observable difference. Common attributes of
successful programs included simpliﬁed treatment 
regimens, facilitation of provider-patient relationships,
and multi-faceted patient education methods. Combina-
tion interventions had higher rates of success than indi-
vidual tactics.
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DIFFERENTIAL ECONOMIC IMPACT OF
VARIABLE COMPLIANCE AND VARIABLE
PERSISTENCE WITH PRESCRIBED, LONG-TERM
DRUG REGIMENS
Vrijens B1,Tousset E1, Koncz T2, Métry JM2, Urquhart J3
1AARDEX Ltd,Vise, Belgium; 2AARDEX Ltd, Zug, Switzerland;
3AARDEX Ltd, Palo Alto, CA, USA
OBJECTIVES: We deﬁne “compliance” as the “the extent
of correspondence between the patient’s dosing history
and the prescribed dosing regimen”, and “persistence” as
the time between the ﬁrst- and last-taken doses. They are
related in that persistence increases one dose at a time.
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Shortfalls in both have differing economic consequences.
The frequency distribution of drug intake is remarkably
similar across disparate diseases and drugs, though poor
methods and terminology have led many to believe 
otherwise. METHODS: There was similarity in 275
patients electronically monitored for 1–12 months,
receiving pharmacotherapy for glaucoma, epilepsy, or
ankylosing spondylitis. We transformed these data into 
a frequency distribution of time-to-consume a 60-day
supply of drug, which ranged from 60–422 days, with a
median of 71 and a mean of 78 days, i.e., a mean of 4.7
reﬁlls/year instead of the prescribed 6—a 22% shortfall
in reﬁlls and revenues. RESULTS: We projected the
impact of variable persistence using a model expressing
patients’ movements between: treated, never treated, 
formerly treated, dead or otherwise untreatable. We used
published data on statin persistence to analyze various
scenarios. With ﬁxed monthly recruitment of patients into
treatment, the divergence in revenues from the “perfect
persistence” scenario is projected to result at the 15 year
point in an ~80% shortfall in annual revenues. CON-
CLUSIONS: Published data may underestimate generally
prevailing persistence, which would lessen the shortfall in
revenues, but the impact on proﬁts appears to be strik-
ingly high. Methods that efﬁciently extend persistence are
needed for the beneﬁt of all parties.
HEALTHCARE POLICY—Consumer Role in
Healthcare Studies
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FEASIBILITY OF HEALTH AND WELLNESS
PROGRAMS VIA AN EMPLOYER-BASED
INTRANET SITE
Whalen EB1,Thomas P2, Leddy S1
1Schering-Plough, Kenilworth, NJ, USA; 2Lockheed Martin,
Marietta, GA, USA
OBJECTIVE: To evaluate the feasibility of implementing
a health and wellness program via a corporate intranet
site. METHODS: A health and wellness program,
addressing the impact of allergy symptoms and treatment
on employees, was developed by a national employer and
a pharmaceutical company. Employees at three locations
(in the West, Southeast and Southwest) were invited to
participate via their corporate intranet in a program 
that included links to web-based health education and an
anonymous allergy survey. Respondents, who were 
self-identiﬁed allergy sufferers, provided information that
included allergy symptom and treatment experience,
knowledge of allergy triggers, quality of life impact, and
lost work hours. RESULTS: An email containing program
background and links to the survey and web-based edu-
cation was sent to 22,000 employees, 50% of whom have
direct access to the company intranet. Assuming average
allergy prevalence of 20%, 400 employees completed the
survey, representing an 18% response rate. This response
rate is similar to that achieved via a 1-time mail admin-
istration. Consistent with data obtained through random
samples, employees were more likely to suffer from sea-
sonal allergies (65.8%), feel that their allergies were only
under “fairly good control” (49.5%), and experience
work loss (12.8 mean hours/per month) due to full or
partial missed days or reduced effectiveness at work. In
addition to willingness to answer questions about allergy
symptomatology, knowledge, work attendance and 
performance, 80% of responders also answered
lifestyle/health risk questions pertaining to issues such as
nutrition, exercise and cigarette and alcohol consump-
tion. CONCLUSIONS: This project demonstrates that
communication of a health and wellness program to
employees via corporate intranet can generate interest
and signiﬁcant involvement at levels equal to or greater
than other approaches to work-site health education.
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IMPACT OF RISK DISCLOSURES IN DIRECT-
TO-CONSUMER ADVERTISING ON ELDERLY
CONSUMERS’ BEHAVIORAL INTENT
Nikam PT, Pathak DS, Unnava HR, Dasta JF
The Ohio State University, Columbus, OH, USA
OBJECTIVE: The new FDA guidelines on direct-to-
consumer (DTC) advertising of prescription drugs require
the sponsor to present balanced risk-beneﬁt information.
However, data suggests frequent lack of compliance with
these guidelines. Misinformation to consumers can have
serious implications on health and safety, especially in 
the elderly population who are more likely to respond to
promotion. The objective of this study is to explore the
impact of variations in risk disclosures through DTC
print advertisements on elderly consumer behavior.
METHOD: A 2 ¥ 2 between-subjects factorial design was
implemented, where the risk statements in the advertise-
ments varied in number (two vs. four) and speciﬁcity (spe-
ciﬁc vs. general). A convenience sample of 200 elderly (60
years) male and female participants was recruited from
Central Ohio. Participants were randomly assigned to one
of the four treatment groups and were asked to read a
print advertisement for a ﬁctitious anti-arthritic drug.
Afterwards, each participant completed a questionnaire.
The dependent variables were: attitude toward the 
advertised drug, intentions to seek additional informa-
tion, intentions to seek advice from healthcare profes-
sionals, and to adopt the advertised drug. A multivariate
analysis of variance was conducted to evaluate the impact
of the two independent variables (number and speciﬁcity
of risk statements) on the dependent variables. RESULTS:
Participants exposed to speciﬁc risk statements are less
likely to look for additional information (p < 0.01) and
adopt the advertised drug (p < 0.01). Additionally, they
hold less favorable attitudes toward the advertised drug
(p < 0.01) as compared to those presented with general
risk statements. The number of risk statements presented
affected neither attitude toward the advertised drug nor
behavioral intentions. CONCLUSION: Speciﬁcity of risk
information presented in the print drug advertisements 
is a key determinant of elderly consumer attitudes and
